ATE342059T1 - Verwendung zur verabreichung von östrogen - Google Patents

Verwendung zur verabreichung von östrogen

Info

Publication number
ATE342059T1
ATE342059T1 AT95929349T AT95929349T ATE342059T1 AT E342059 T1 ATE342059 T1 AT E342059T1 AT 95929349 T AT95929349 T AT 95929349T AT 95929349 T AT95929349 T AT 95929349T AT E342059 T1 ATE342059 T1 AT E342059T1
Authority
AT
Austria
Prior art keywords
estrogen
administration
glycoside
menopause
alleviation
Prior art date
Application number
AT95929349T
Other languages
English (en)
Inventor
Michael F Holick
Original Assignee
Michael F Holick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael F Holick filed Critical Michael F Holick
Application granted granted Critical
Publication of ATE342059T1 publication Critical patent/ATE342059T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95929349T 1994-08-04 1995-08-03 Verwendung zur verabreichung von östrogen ATE342059T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/285,438 US5612317A (en) 1994-08-04 1994-08-04 Method for delivering estrogen

Publications (1)

Publication Number Publication Date
ATE342059T1 true ATE342059T1 (de) 2006-11-15

Family

ID=23094228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929349T ATE342059T1 (de) 1994-08-04 1995-08-03 Verwendung zur verabreichung von östrogen

Country Status (7)

Country Link
US (1) US5612317A (de)
EP (1) EP0894000B1 (de)
AT (1) ATE342059T1 (de)
CA (1) CA2226140C (de)
DE (1) DE69535267T2 (de)
ES (1) ES2274519T3 (de)
WO (1) WO1996003995A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087420B1 (en) 1997-07-17 2006-08-08 Cambia Microbial β-glucuronidase genes, gene products and uses thereof
US6391547B1 (en) * 1997-09-09 2002-05-21 Center For The Application Of Molecular Biology To International Agriculture Microbial β-glucuronidase genes, gene products and uses thereof
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
CN1250563C (zh) 1999-05-04 2006-04-12 斯特拉坎有限公司 雄激素糖苷及其产生雄性征的活性
AU7674000A (en) * 1999-10-08 2001-04-23 Strakan Group Plc Tamoxifen and tamoxifen analogue glycosides and uses thereof
WO2001027129A1 (en) * 1999-10-08 2001-04-19 Strakan Limited Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof
EP1421100B1 (de) * 2001-08-21 2008-07-09 GlycoMed Sciences Limited Chemische synthese von solamargin
CN1649600A (zh) 2002-02-28 2005-08-03 A&D生物科学公司 氟西汀及类似物的糖醛酰胺、苷和原酸酯苷及其应用
DE10238390A1 (de) * 2002-08-16 2004-02-26 Stern, René Medizinisches Versorgungs- und Transportmodul
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
US4096254A (en) * 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4410515A (en) * 1981-04-01 1983-10-18 Massachusetts General Hospital Vitamin D glycosides and a method of use
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters
DE3888269T2 (de) * 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
EP0322020A1 (de) * 1987-12-22 1989-06-28 Akzo N.V. Pharmazeutische Dosierungseinheit zur Behandlung von klimakterischen Beschwerden und Osteoporosis
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product

Also Published As

Publication number Publication date
US5612317A (en) 1997-03-18
DE69535267D1 (de) 2006-11-23
CA2226140A1 (en) 1996-02-15
ES2274519T3 (es) 2007-05-16
DE69535267T2 (de) 2007-05-24
EP0894000A4 (de) 2001-04-04
EP0894000A1 (de) 1999-02-03
EP0894000B1 (de) 2006-10-11
WO1996003995A1 (en) 1996-02-15
CA2226140C (en) 2001-10-23

Similar Documents

Publication Publication Date Title
ATE259215T1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
ATE281170T1 (de) Verwendung von steroiden zur behandlung von asthma und atemwegerkrankungen
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
YU7797A (sh) Kombinovana terapija za osteoporozu
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
MXPA97001884A (es) Composiciones para el tratamiento de trastornos enla piel.
ATE227567T1 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
ATE342059T1 (de) Verwendung zur verabreichung von östrogen
BG102818A (en) D-manitol and method for its preparation
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69629023D1 (de) Piperazino-derivative als neurokininantagonisten
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
IL143516A0 (en) COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B
MY120530A (en) Combination preparation for use in dementia
DE69606321T3 (de) Verwendung von 2-Ethylhexyl-alpha-cyano-beta, beta-diphenylacrylat zur Verbesserung der Lichtstabilität von p-Methylbenzylidencampher
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE229336T1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern
DE60020970D1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf-erkrankungen
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties